News
ISRG
468.87
+2.16%
9.91
Intuitive Surgical Is Maintained at Neutral by Mizuho
Dow Jones · 1d ago
Intuitive Surgical Price Target Cut to $525.00/Share From $575.00 by Mizuho
Dow Jones · 1d ago
Mizuho Maintains Neutral on Intuitive Surgical, Lowers Price Target to $525
Benzinga · 1d ago
Encision FY26 Q4 net loss narrows 69.4% to 96; net sales fall 12.2% to 1,241
PUBT · 1d ago
Intuitive Surgical price target lowered to $525 from $575 at Mizuho
TipRanks · 1d ago
Intuitive Surgical price target lowered to $574 from $616 at BTIG
TipRanks · 1d ago
INTUITIVE SURGICAL INC <ISRG.O>: BTIG CUTS TARGET PRICE TO $574 FROM $616
Reuters · 1d ago
INTUITIVE SURGICAL INC <ISRG.O>: MIZUHO CUTS TARGET PRICE TO $525 FROM $575
Reuters · 1d ago
Weekly Report: what happened at ISRG last week (0406-0410)?
Weekly Report · 1d ago
These 3 Stocks Have Crushed the Market, and the Next 10 Years Could Be Even Better
The Motley Fool · 1d ago
A Look At Intuitive Surgical (ISRG) Valuation As Hedge Funds React To Procedure Growth And da Vinci 5 Rollout
Simply Wall St · 1d ago
Mental Tips, Tricks & Lifehacks, Vol. 11
The Motley Fool · 3d ago
Intuitive Surgical (ISRG) Gets a Buy from BTIG
TipRanks · 3d ago
How Investors May Respond To Intuitive Surgical (ISRG) Robust Procedure Outlook And Da Vinci 5 Rollout
Simply Wall St · 4d ago
If You Invested $1000 In Intuitive Surgical Stock 10 Years Ago, You Would Have This Much Today
Benzinga · 4d ago
Intuitive Surgical Price Target Maintained With a $616.00/Share by BTIG
Dow Jones · 4d ago
BTIG Reiterates Buy on Intuitive Surgical, Maintains $616 Price Target
Benzinga · 4d ago
Market Crash: The Healthcare Stocks I'd Buy Without Hesitation
The Motley Fool · 4d ago
Intuitive Surgical Price Target Cut to $609.00/Share From $714.00 by Goldman Sachs
Dow Jones · 5d ago
Intuitive Surgical Is Maintained at Buy by Goldman Sachs
Dow Jones · 5d ago
More
Webull provides a variety of real-time ISRG stock news. You can receive the latest news about Intuitive Surgical Inc through multiple platforms. This information may help you make smarter investment decisions.
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.